Get the Stockscreener App
18.53
0.59%
-0.11
Mediwound Ltd stock is traded at $18.53, with a volume of 53,903.
It is down -0.59% in the last 24 hours and down -3.49% over the past month.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
See More
Previous Close:
$18.64
Open:
$18.4
24h Volume:
53,903
Relative Volume:
0.87
Market Cap:
$200.27M
Revenue:
$19.85M
Net Income/Loss:
$-12.75M
P/E Ratio:
-13.43
EPS:
-1.38
Net Cash Flow:
$-21.94M
1W Performance:
-8.85%
1M Performance:
-3.49%
6M Performance:
-5.36%
1Y Performance:
+6.13%
1-Day Range:
$18.28
$18.93
1-Week Range:
$18.28
$20.62
52-Week Range:
$14.14
$22.50
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
18.53 | 201.46M | 19.85M | -12.75M | -21.94M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| May-02-25 | Initiated | Alliance Global Partners | Buy |
| Feb-28-25 | Initiated | Craig Hallum | Buy |
| Jul-16-24 | Reiterated | Maxim Group | Buy |
| Dec-22-22 | Initiated | Maxim Group | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Sep-23-20 | Initiated | BTIG Research | Buy |
| Nov-28-16 | Initiated | Aegis Capital | Buy |
| Aug-17-16 | Initiated | Wells Fargo | Outperform |
| Apr-16-14 | Initiated | Oppenheimer | Outperform |
View All
Mediwound Ltd Stock (MDWD) Latest News
Volatility clustering patterns for MediWound Ltd.Free Entry and Exit Strategy Optimizer Tool - Newser
MediWound Ltd. Company’s Quarterly Earnings Growth: What the Numbers SayFree Entry Zone Strategy for Consistent Profit - Newser
Investor Network: MediWound Ltd. to Host Earnings Call - ACCESS Newswire
While shareholders of MediWound (NASDAQ:MDWD) are in the black over 3 years, those who bought a week ago aren't so fortunate - simplywall.st
What markets is VRME expanding into Is MediWound Ltd. stock a good long term investment optionDaily Trading Recommendation For Smart Trading - jammulinksnews.com
Is MediWound Ltd. stock a good hedge against inflationFree Price Action Based Buy Opportunity List - Newser
What are MediWound Ltd. company’s key revenue driversMarket Forecast Alerts Backed By Experts - jammulinksnews.com
Published on: 2025-07-31 22:15:35 - metal.it
Real time social sentiment graph for MediWound Ltd.Free Watchlist for Smart Swing Trading - Newser
Top chart patterns to watch in MediWound Ltd.Buy/Sell Zone Confirmation Technical Analysis - Newser
Varicose Ulcer Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | MediWound Ltd., Xinnate AB - Barchart.com
Why MediWound Ltd. stock attracts strong analyst attentionPortfolio Positioning Strategy With Timing - Newser
When is the best time to buy MediWound Ltd. stockFree Breakout Confirmation With Entry Tracker - Newser
MediWound Ltd. stock outlook for YEARHistorical Market Behavior and Trend Summary - Newser
How to use a screener to detect MediWound Ltd. breakoutsFree Daily Volume Spike Trading Signals - Newser
What is the risk reward ratio of investing in MediWound Ltd. stockBreakthrough stock performance - jammulinksnews.com
How strong is MediWound Ltd. company’s balance sheetInvest confidently with expert support - jammulinksnews.com
What makes MediWound Ltd. stock price move sharplyCapitalize on market trends with confidence - jammulinksnews.com
How does MediWound Ltd. compare to its industry peersNavigate market shifts with confidence - jammulinksnews.com
Is MediWound Ltd. a growth stock or a value stockHigh-yield capital appreciation - jammulinksnews.com
How Resilient Is MediWound Ltd. Stock During Economic DownturnsElite Stock Shortlist - Newser
What drives MediWound Ltd. stock priceConsistent wealth multiplication - PrintWeekIndia
What institutions are buying MediWound Ltd. stock nowDynamic portfolio growth - jammulinksnews.com
MediWound Ltd. Stock Analysis and ForecastTriple-digit wealth increases - PrintWeekIndia
Will MediWound Ltd. stock split in the near futureMassive wealth growth - jammulinksnews.com
What analysts say about MediWound Ltd. stockMarket-leading profit generation - PrintWeekIndia
Here's What Could Help MediWound (MDWD) Maintain Its Recent Price Strength - Yahoo Finance
Is MediWound Ltd. a good long term investmentOverwhelming profit margins - jammulinksnews.com
Mediwound Ltd Stock (MDWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):